Ignite Creation Date:
2025-12-24 @ 9:44 PM
Ignite Modification Date:
2025-12-25 @ 7:24 PM
Study NCT ID:
NCT01627132
Status:
UNKNOWN
Last Update Posted:
2012-06-25
First Post:
2012-02-14
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Discontinuation of Dasatinib in Patients With Chronic Myeloid Leukemia-CP Who Have Maintained Complete Molecular Remission for Two Years; Dasatinib Stop Trial
Sponsor:
Shimousa Hematology Study Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-02
Start Date Type:
None
Primary Completion Date:
2017-02
Primary Completion Date Type:
ESTIMATED
Completion Date:
2019-01
Completion Date Type:
ESTIMATED
First Submit Date:
2012-02-14
First Submit QC Date:
None
Study First Post Date:
2012-06-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-06-22
Last Update Post Date:
2012-06-25
Last Update Post Date Type:
ESTIMATED